Lactobacillus plantarum CCFM8610 Alleviates Irritable Bowel Syndrome and Prevents Gut Microbiota Dysbiosis: A Randomized, Double-blind, Placebo-controlled, Pilot Clinical Trial

Prostaglandin E2, Produced by Mast Cells in Colon Tissues from Patients with Irritable Bowel Syndrome, Contributes to Visceral Hypersensitivity in Mice

(2020) Gintautas Grabauskas et al.   GASTROENTEROLOGY

Low-sugar yogurt making by the co-cultivation of Lactobacillus plantarum WCFS1 with yogurt starter cultures

(2020) S.S. Zhang et al.   JOURNAL OF DAIRY SCIENCE

Lactobacillus acidophilus DDS-1 and Bifidobacterium lactis UABla-12 Improve Abdominal Pain Severity and Symptomology in Irritable Bowel Syndrome: Randomized Controlled Trial

(2020) Christopher J. Martoni et al.   Nutrients

Heat-inactivated Bifidobacterium bifidum MIMBb75 (SYN-HI-001) in the treatment of irritable bowel syndrome: a multicentre, randomised, double-blind, placebo-controlled clinical trial

(2020) Viola Andresen et al.   Lancet Gastroenterology & Hepatology

Oral administration of Lactobacillus plantarum strains increases cadmium excretion by regulating enterohepatic circulation in mice

(2019) Qixiao Zhai et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Butyrate Protects Mice from Clostridium difficile-Induced Colitis through an HIF-1-Dependent Mechanism

(2019) José Luís Fachi et al.   Cell Reports

Probiotics modulate the gut microbiota composition and immune responses in patients with atopic dermatitis: a pilot study

(2019) Zhifeng Fang et al.   EUROPEAN JOURNAL OF NUTRITION

Prebiotics and probiotics for depression and anxiety: A systematic review and meta-analysis of controlled clinical trials

(2019) Richard T. Liu et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Members of the Lactobacillus Genus Complex (LGC) as Opportunistic Pathogens: A Review

(2019) Franca Rossi et al.   Microorganisms

Effects of Irritable Bowel Syndrome on Daily Activities Vary Among Subtypes Based on Results From the IBS in America Survey

(2019) Sarah Ballou et al.   Clinical Gastroenterology and Hepatology

The Microbiota-Gut-Brain Axis

(2019) John F. Cryan et al.   PHYSIOLOGICAL REVIEWS

The Potential Role of Gut Mycobiome in Irritable Bowel Syndrome

(2019) Yu Gu et al.   Frontiers in Microbiology

Current US Food and Drug Administration-Approved Pharmacologic Therapies for the Treatment of Irritable Bowel Syndrome with Diarrhea

(2019) Darren M. Brenner et al.   ADVANCES IN THERAPY

Higher prevalence of irritable bowel syndrome and greater gastrointestinal symptoms in obsessive-compulsive disorder

(2019) Jasmine Turna et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Genomic and epidemiological evidence of bacterial transmission from probiotic capsule to blood in ICU patients

(2019) Idan Yelin et al.   NATURE MEDICINE

Bilophila wadsworthia aggravates high fat diet induced metabolic dysfunctions in mice

(2018) Jane M. Natividad et al.   Nature Communications

The effect of Clostridium butyricum on symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial

(2018) Yi-Yuan Sun et al.   Scientific Reports

Butyrate: A Double-Edged Sword for Health?

(2018) Hu Liu et al.   Advances in Nutrition

Chronic abdominal pain in irritable bowel syndrome – current and future therapies

(2018) Anna Zielińska et al.   Expert Review of Clinical Pharmacology

Sustainable Management and Action in China under the Increasing Risks of Global Climate Change

(2018) Yihui Ding   Engineering

A low FODMAP diet is associated with changes in the microbiota and reduction in breath hydrogen but not colonic volume in healthy subjects

(2018) Tim J. Sloan et al.   PLoS One

Effect of probiotic Bifidobacterium bifidum G9-1 on the relationship between gut microbiota profile and stress sensitivity in maternally separated rats

(2018) Hirokazu Fukui et al.   Scientific Reports

Infectious complications following probiotic ingestion: a potentially underestimated problem? A systematic review of reports and case series

(2018) Rafael Lessa Costa et al.   BMC Complementary and Alternative Medicine

Enhancing Clinical Efficacy through the Gut Microbiota: A New Field of Traditional Chinese Medicine

(2018) Yan-Meng Lu et al.   Engineering

Prebiotics in irritable bowel syndrome and other functional bowel disorders in adults: a systematic review and meta-analysis of randomized controlled trials

(2018) Bridgette Wilson et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome

(2017) Julien Tap et al.   GASTROENTEROLOGY

Risks of Saccharomyces boulardii -Containing Probiotics for the Prevention of  Clostridium difficile Infection in the Elderly

(2017) Nicolas Dauby   GASTROENTEROLOGY

Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome

(2017) Maria Ines Pinto-Sanchez et al.   GASTROENTEROLOGY

Health-related quality of life, work productivity, and indirect costs among patients with irritable bowel syndrome with diarrhea

(2017) Jessica L. Buono et al.   Health and Quality of Life Outcomes

Bacteroidales recruit IL-6-producing intraepithelial lymphocytes in the colon to promote barrier integrity

(2017) K A Kuhn et al.   Mucosal Immunology

Irritable Bowel Syndrome

(2017) Alexander C. Ford et al.   NEW ENGLAND JOURNAL OF MEDICINE

Transplantation of fecal microbiota from patients with irritable bowel syndrome alters gut function and behavior in recipient mice

(2017) Giada De Palma et al.   Science Translational Medicine

Metagenomic insights into the effects of oligosaccharides on the microbial composition of cecal contents in constipated mice

(2017) Linlin Wang et al.   Journal of Functional Foods

Non-digestible oligosaccharides directly regulate host kinome to modulate host inflammatory responses without alterations in the gut microbiota

(2017) Richard Y. Wu et al.   Microbiome

Methanobrevibacter attenuation via probiotic intervention reduces flatulence in adult human: A non-randomised paired-design clinical trial of efficacy

(2017) Minseok Seo et al.   PLoS One

Similar Fecal Microbiota Signatures in Patients With Diarrhea-Predominant Irritable Bowel Syndrome and Patients With Depression

(2016) Yixuan Liu et al.   Clinical Gastroenterology and Hepatology

The neuropharmacology of butyrate: The bread and butter of the microbiota-gut-brain axis?

(2016) Roman M. Stilling et al.   NEUROCHEMISTRY INTERNATIONAL

Eluxadoline for Irritable Bowel Syndrome with Diarrhea

(2016) Anthony J. Lembo et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Role of Visceral Hypersensitivity in Irritable Bowel Syndrome: Pharmacological Targets and Novel Treatments

(2016) Mohammad H Farzaei et al.   Journal of Neurogastroenterology and Motility

Comparison of faecal microbiota in Blastocystis-positive and Blastocystis-negative irritable bowel syndrome patients

(2016) Robyn Nagel et al.   Microbiome

An In Vitro Approach to Study Effects of Prebiotics and Probiotics on the Faecal Microbiota and Selected Immune Parameters Relevant to the Elderly

(2016) Yue Liu et al.   PLoS One

Risk and Safety of Probiotics

(2015) Shira Doron et al.   CLINICAL INFECTIOUS DISEASES

Synbiotic functional drink from Jerusalem artichoke juice fermented by probiotic Lactobacillus plantarum PCS26

(2015) Darko Dimitrovski et al.   JOURNAL OF FOOD SCIENCE AND TECHNOLOGY-MYSORE

Differences of microbiota in small bowel and faeces between irritable bowel syndrome patients and healthy subjects

(2015) Chen-Shuan Chung et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation

(2015) Prashant Singh   WORLD JOURNAL OF GASTROENTEROLOGY

Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome

(2015) Marta Pozuelo et al.   Scientific Reports

The Placebo Effect: the Good, the Bad, and the Ugly

(2014) Morton E. Tavel   AMERICAN JOURNAL OF MEDICINE

Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis

(2014) Guillaume Fond et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

Prevalence, investigational pathways and diagnostic outcomes in differing irritable bowel syndrome subtypes

(2014) Simone Lin et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Unclear Abdominal Discomfort: Pivotal Role of Carbohydrate Malabsorption

(2014) Miriam Goebel-Stengel et al.   Journal of Neurogastroenterology and Motility

Sodium butyrate and short chain fatty acids in prevention of travellers' diarrhoea: A randomized prospective study

(2013) Lukasz Krokowicz et al.   Travel Medicine and Infectious Disease

Protective Effects of Lactobacillus plantarum CCFM8610 against Acute Cadmium Toxicity in Mice

(2012) Qixiao Zhai et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis

(2012) Rebecca M. Lovell et al.   Clinical Gastroenterology and Hepatology

Global and Deep Molecular Analysis of Microbiota Signatures in Fecal Samples From Patients With Irritable Bowel Syndrome

(2011) Mirjana Rajilić–Stojanović et al.   GASTROENTEROLOGY

Increased Proteasome-Mediated Degradation of Occludin in Irritable Bowel Syndrome

(2009) Moïse Coëffier et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome

(2008) D. B. A. SILK et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS